For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Campath 1-H | Campath-1H: two intravenous 20mg/m2/doses, the first on the day of transplant and the second dose on day 1 post transplant | 0 | None | 2 | 33 | 29 | 33 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Fever | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Gingivitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| influenza | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Urinary Tract Infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Pseudomonas bacteremia | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Varicella | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Ureteral Stricture | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Pneumonia | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Seizure | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Small Bowel Obstruction | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Pyelonephritis | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Hydronephrosis | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Epigastric Pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Hydroureter | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Elevated Creatinine | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Increased Proteinuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Pyuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Renal Insufficiency | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Urinary Eosinophils | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Bronchitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Bronchospasm | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Pulmonary Edema | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Shortness of Breath | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Nasal Congestion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Rhinorrhea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Sore Throat | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Tonsillar cervical, axillary, inguinal hypertrophy | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Anemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hyperglycemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hyperkalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hyperphosphatemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Weight Loss | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Metabolic acidosis | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Mouth Ulcers | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Hives | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Chest Pain | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| fatigue | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Nausea and Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Headache | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Joint Pain | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Eosinophilia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Leukopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Lymphoid hyperplasia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Fine tremor at rest | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Fracture L5 | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| High Blood Pressure | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Hepatosplenomegaly | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Left ventricular hypertrophy | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Ottis Media | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |